2061
CASE REPORT: We report a patient who developed a DAT-positive hemolytic episode after a red cell (RBC) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin.
 ( adverse event: after ,  a patient: Subject, developed a DAT-positive hemolytic episode: Effect, a red cell (RBC) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin: Treatment, oxaliplatin: Treatment.Drug, a red cell: Treatment.Drug, infusion: Treatment.Route, transfusion: Treatment.Route, 17th cycle: Treatment.Duration, oxaliplatin: Combination.Drug, a red cell: Combination.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: after ,  a patient: Subject, developed a DAT-positive hemolytic episode: Effect, a red cell (RBC) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin: Treatment, oxaliplatin: Treatment.Drug, a red cell: Treatment.Drug, infusion: Treatment.Route, transfusion: Treatment.Route, 17th cycle: Treatment.Duration, oxaliplatin: Combination.Drug, a red cell: Combination.Drug) 